3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Dendritic Cell Sarcoma, Interdigitating
1
Dementia
1
Interventions
Cyclophosphamide
76
fludarabine phosphate
41
Filgrastim
38
Peripheral Blood Stem Cell Transplantation
34
Radiotherapy
33
Cyclosporine
32
Busulfan
31
Etoposide
30
Mycophenolic Acid
29
Antilymphocyte Serum
28
Whole-Body Irradiation
25
Methotrexate
25
Rituximab
22
Melphalan
21
Methylprednisolone
20
Vincristine
17
Tacrolimus
16
Doxorubicin
16
Cytarabine
16
Cord Blood Stem Cell Transplantation
16
Prednisone
15
Thiotepa
10
Granulocyte Colony-Stimulating Factor
9
Carboplatin
8
Leucovorin
7
fludarabine
6
aldesleukin
6
Ifosfamide
6
sargramostim
5
Sirolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Dendritic Cell Sarcoma, Interdigitating
×
Activities of Daily Living
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled